Clinical Trial

Effects of Real-time Continuous Glucose Monitoring System on Hospital-to-home Transitional Blood Glucose Control

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2024 (before its estimated March 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
Glucose monitoring is an important part of self-management for patients with diabetes. The results of glucose monitoring not only help to assess the degree of glucose metabolism disorders in patients, but also help physicians to make clinical decisions and guide patients in self-management. Despite extensive efforts and advances in diabetes management during hospitalization, glucose control after patients is discharged home remains a challenge. This trial aims to explore the effect of real-time continuous glucose monitoring (RT-CGM) system compared to self-monitoring of blood glucose (SMBG) group on glucose and self-efficacy of type 2 diabetes patients treated with insulin after discharge from the hospital.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-09-07; most recent amendment 2024-11-26.
Status change: Not Yet Recruiting → Recruiting 2024-11-26
Trial Details
NCT Number NCT06591286
Lead Sponsor Shanghai 6th People's Hospital
Conditions Diabetes Mellitus, Type 2
Enrollment 150 participants
Start Date 2024-10-25
Primary Completion 2026-03-10 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-11-29